for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Cardinal Health Inc

CAH.N

Latest Trade

48.40USD

Change

0.38(+0.79%)

Volume

536,143

Today's Range

48.32

 - 

49.09

52 Week Range

41.03

 - 

58.31

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
48.02
Open
48.60
Volume
536,143
3M AVG Volume
59.97
Today's High
49.09
Today's Low
48.32
52 Week High
58.31
52 Week Low
41.03
Shares Out (MIL)
298.13
Market Cap (MIL)
14,274.64
Forward P/E
9.57
Dividend (Yield %)
4.02

Next Event

Dividend For CAH.N - 0.4811 USD

Latest Developments

More

Cardinal Health Files For Potential Mixed Shelf Offering, Size Not Disclosed

Cardinal Health, On Opioid Lawsuits, Says Defense & Resolution Of Lawsuits Could Have A Material Adverse Effect On Results Of Operations

Cardinal Health Inc Says On August 7, Appointed David Evans As Interim Chief Financial Officer Of Company, Effective September 1, 2019

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Cardinal Health Inc

Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.

Industry

Biotechnology & Drugs

Contact Info

7000 Cardinal Pl

+1.614.7573033

https://www.cardinalhealth.com/en.html

Executive Leadership

Gregory B. Kenny

Non-Executive Chairman of the Board

Michael C. Kaufmann

Chief Executive Officer, Director

David C. Evans

Interim Chief Financial Officer

Stephen M Mason

Chief Executive Officer-Medical Segment

Pamela O. Kimmet

Chief Human Resource Officer

Key Stats

3.05 mean rating - 19 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

130.0K

2018

136.8K

2019

145.5K

2020(E)

152.2K
EPS (USD)

2017

5.400

2018

5.000

2019

5.280

2020(E)

5.003
Price To Earnings (TTM)
10.61
Price To Sales (TTM)
0.10
Price To Book (MRQ)
2.26
Price To Cash Flow (TTM)
6.03
Total Debt To Equity (MRQ)
126.91
LT Debt To Equity (MRQ)
119.77
Return on Investment (TTM)
8.06
Return on Equity (TTM)
3.38

Latest News

Cardinal Health warns ongoing opioid-related lawsuits to hit business

Drug distributor Cardinal Health Inc warned on Tuesday that its business could be hurt as it defends itself against several opioid-related lawsuits.

Cardinal Health says opioid-related lawsuits to hurt business

Drug distributor Cardinal Health Inc warned on Tuesday that its business could take a hit as it defends itself against a host of opioid-related lawsuits.

U.S. Drug distributors propose $10 billion to end state lawsuits over opioids: Bloomberg

Drug wholesalers AmerisourceBergen Corp <ABC.N>, McKesson Corp <MCK.N> and Cardinal Health Inc <CAH.N> have proposed a $10 billion settlement for claims that they played a part in the U.S. opioid epidemic, Bloomberg reported on Tuesday, citing people familiar with negotiations...

UPDATE 1-Drug distributor Cardinal's profit beats on pharma unit strength

U.S. drug distributor Cardinal Health Inc beat analyst estimates for adjusted fourth-quarter profit on Monday, supported by higher sales in its pharmaceutical and medical devices businesses.

Cardinal Health posts fourth-quarter loss

Cardinal Health Inc reported a fourth-quarter loss compared to a year-ago profit, as the U.S. drug distributor was hit by an asset-impairment charge of $1.35 billion.

Cardinal Health misses profit on Cordis woes, shares fall

Cardinal Health Inc's <CAH.N> quarterly profit missed analysts' expectations as inventory and cost issues hurt its Cordis medical device unit, and the U.S. drug distributor said it saw prices of generic drugs fall more than expected.

Drug distributor Cardinal Health's quarterly profit falls 33 pct

U.S. drug distributor Cardinal Health Inc posted a 33 percent fall in quarterly profit on Thursday, hurt by a change in the company's effective tax rate primarily associated with its Cordis business.

BRIEF-Cardinal Health Reports Q3 Non-GAAP Earnings Per Share $1.39

* CARDINAL HEALTH REPORTS THIRD-QUARTER RESULTS FOR FISCAL YEAR 2018

BRIEF-Cardinal Health Recommends Shareholders Reject The Below-Market Mini-Tender Offer By TRC Capital Corporation

* CARDINAL HEALTH RECOMMENDS SHAREHOLDERS REJECT THE BELOW-MARKET MINI-TENDER OFFER BY TRC CAPITAL CORPORATION

UPDATE 1-Kentucky accuses Cardinal Health of contributing to opioid epidemic

Kentucky's attorney general on Monday filed a lawsuit against drug distributor Cardinal Health Inc , accusing it of contributing to the opioid epidemic by failing to halt or report suspiciously large or frequent orders by pharmacies of prescription painkillers.

Kentucky accuses Cardinal Health of contributing to opioid epidemic

Kentucky's attorney general on Monday accused the drug distributor Cardinal Health Inc of contributing to the opioid epidemic by failing to halt or report suspiciously large or frequent orders by pharmacies of prescription painkillers.

BRIEF-Barrow, Hanley, Mewhinney & Strauss, Llc Reports 5.68 Percent Passive Stake In Cardinal Health Inc As Of December 31, 2017

* BARROW, HANLEY, MEWHINNEY & STRAUSS, LLC REPORTS 5.68 PERCENT PASSIVE STAKE IN CARDINAL HEALTH INC AS OF DECEMBER 31, 2017 - SEC FILING Source text (http://bit.ly/2CfIHSC) Further company coverage:

Cardinal Health profit beats on CVS tie-up, Medtronic unit buy

Cardinal Health's <CAH.N> quarterly profit topped analysts' estimates as the U.S. drug distributor benefited from its purchase of Medtronic Plc's <MDT.N> patient care business and a tie-up with drugstore chain CVS Health Corp <CVS.N>.

BRIEF-Cardinal Health Reports Q2 Adj. Earnings Per Share $1.31

* CARDINAL HEALTH REPORTS SECOND-QUARTER RESULTS FOR FISCAL YEAR 2018

Cardinal Health's quarterly profit surges

Cardinal Health said on Thursday its quarterly profit more than tripled due to a benefit related to recent changes in U.S. tax laws.

BRIEF-Cardinal Health Adds Akhil Johri To Its Board Of Directors

* CARDINAL HEALTH INC - WITH JOHRI'S ADDITION, BOARD WILL CONSIST OF THIRTEEN DIRECTORS Source text for Eikon: Further company coverage:

BRIEF-Cordis And Medinol Announce FDA Approval Of EluNIR Drug-Eluting Stent System

* CORDIS AND MEDINOL ANNOUNCE FDA APPROVAL OF THE INNOVATIVE ELUNIR DRUG-ELUTING STENT SYSTEM Source text for Eikon: Further company coverage:

UPDATE 3-Shanghai Pharma buys U.S. Cardinal Health's China business for $557 mln

* Cardinal Health put business up for sale due to rule changes

Shanghai Pharma buys U.S. Cardinal Health's China business for $557 mln

State-owned Shanghai Pharmaceuticals Holding Co has agreed to acquire Cardinal Health Inc's China business, one of the nation's largest drug distributors, for $557 million.

BRIEF-Cardinal Health to sell its china business to Shanghai Pharma for $1.2 bln

* Cardinal health signs definitive agreement to sell its china business to Shanghai Pharma

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up